Medication Adherence in Thoracic Transplant Candidates
1Mayo Clinic, Rochester, MN, 2Cleveland Clinic Foundation, Cleveland, OH, 3University of Florida, Gainesville, FL, 4Mayo Clinic, Jacksonville, FL, 5University of Washington, Seattle, WA, 6University of Texas Health Science Center, San Antonio, TX, 7Mayo Clinic, Scottsdale, AZ
Meeting: 2020 American Transplant Congress
Abstract number: 190
Keywords: Heart/lung transplantation, Lung transplantation, Risk factors, Screening
Session Information
Session Name: Living in the Real World: Decision Making and Outcomes After Lung Transplant
Session Type: Oral Abstract Session
Date: Saturday, May 30, 2020
Session Time: 3:15pm-4:45pm
Presentation Time: 4:03pm-4:15pm
Location: Virtual
*Purpose: Medication non-adherence is associated with poor outcomes in transplant recipients. It can be challenging to identify candidates at risk for medication non-adherence. The simplified medication adherence questionnaire (SMAQ) is an instrument designed to assess medication adherence. The aim of this study was to evaluate factors associated with medication adherence in thoracic transplant candidates.
*Methods: A questionnaire, including the SMAQ, was mailed to waitlisted thoracic transplant candidates at 6 transplant centers. Recruitment occurred from 9/16/2015 to 11/19/2019. Medication adherence or non-adherence by SMAQ is binary. Medication non-adherence is defined as a positive response to any of the qualitative SMAQ questions, missing more than two doses of any scheduled medication over the preceding week, or missing more than two cumulative days of all medications over the preceding 3 months. A chi2 test was performed to examine the relation between demographic factors and medication adherence. The association of positive attitude, as defined by a positivity ratio of >2.9 on the Positive and Negative Affect Schedule, and medication adherence was also examined using chi2. Self-management ability, as assessed by the Self-Management Ability Scale (SMAS-30), was compared in medication adherent and non-adherent candidates using a t-test. We set an alpha level of 0.05.
*Results: Questionnaires were completed by 314 candidates (77.5% participation). 179 (57.0%) respondents were medication non-adherent: 96 (60.8%) heart transplant, 81 (54.0%) lung transplant, and 2 (33.3%) combined heart-lung transplant candidates. Male candidates (p=0.05), candidates with at least some college (p=0.05), and obese candidates (p=0.05) were more likely to be medication non-adherent. In contrast, candidates with a positive attitude were more likely to be medication adherent (p=0.02). While the SMAS-30 total score was similar in medication adherent (74.24 + 13.40) compared to medication non-adherent (69.94 + 12.24, p=0.08) candidates, medication non-adherent candidates had lower mean investment behavior SMAS sub-scores (68.67 + 18.24) compared to medication adherent (73.81 + 18.88, p=0.02) candidates.
*Conclusions: Male sex, obesity, and higher education were associated with medication non-adherence. Candidates with positive attitude and more investment behaviors were more likely to be adherent. Given the importance of medication adherence following thoracic transplant, these characteristics can be used to identify and provide appropriate resources to candidates that may be at risk for medication non-adherence.
To cite this abstract in AMA style:
Pennington K, Benzo R, Jowsey S, Budev M, Chandreashekaran S, Erasmus D, Lease E, Levine D, Thompson K, Yip D, Hardaway B, Dunlay S, Kennedy C. Medication Adherence in Thoracic Transplant Candidates [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/medication-adherence-in-thoracic-transplant-candidates/. Accessed November 21, 2024.« Back to 2020 American Transplant Congress